Literature DB >> 28369859

Role of mucosal high-risk human papillomavirus types in head and neck cancers in central India.

Tarik Gheit1, Devasena Anantharaman1,2, Dana Holzinger3, Laia Alemany4, Sara Tous4, Eric Lucas1, Priya Ramesh Prabhu5, Michael Pawlita3, Ruediger Ridder6,7, Susanne Rehm6, Johannes Bogers8, Fausto Maffini9, Susanna Chiocca9, Belén Lloveras10, Rekha Vijay Kumar11, Thara Somanathan12, Silvia de Sanjosé4, Xavier Castellsagué4, Marc Arbyn13, Paul Brennan1, Rengaswamy Sankaranarayanan1, Madhavan Radhakrishna Pillai5, Nitin Gangane14, Massimo Tommasino1.   

Abstract

Mucosal high-risk (HR) human papillomaviruses (HPV) cause a subset of head and neck cancers (HNC). The HPV-attributable fraction of HNC varies substantially between countries. Although HNC has a very high incidence in the Indian subcontinent, information on the contribution of HPV infection is limited. Here, we evaluated the HPV-attributable fraction in HNC (N = 364) collected in a central region of India. HNC from three different anatomical subsites were included, namely, oral cavity (n = 252), oropharynx (n = 53) and hypopharynx/larynx (n = 59). In this retrospective study, HPV-driven HNC were defined by presence of both viral DNA and RNA. Overexpression of p16INK4a was also evaluated. HR-HPV DNA was detected in 13.7% of the cases; however, only 2.7% were positive for both HPV DNA and RNA. The highest percentage of HPV DNA/RNA double positivity was found in oropharynx (9.4%), followed by larynx (1.7%) and oral cavity (1.6%) (p = 0.02). More than half of HPV DNA/RNA-positive cases were p16INK4a -negative, while a considerable number of HPV RNA-negative cases were p16INK4a -positive (17.9%). HPV16 was the major type associated with HNC (60.0%), although cases positive for HPV18, 35 and 56 were also detected. Our data indicate that the proportion and types of mucosal HR-HPV associated with HNC in this central Indian region differ from those in other (developed) parts of the world. This may be explained by differences in smoking and/or sexual behaviour compared with North America and northern Europe. Moreover, we show that p16INK4a staining appeared not to be a good surrogate marker of HPV transformation in the Indian HNC cases.
© 2017 UICC.

Entities:  

Keywords:  HPV; central India; head and neck cancer

Mesh:

Substances:

Year:  2017        PMID: 28369859     DOI: 10.1002/ijc.30712

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  15 in total

Review 1.  Prevalence and Impact of Human Papillomavirus on Head and Neck Cancers: Review of Indian Studies.

Authors:  Deepa Nair; Manish Mair; Arjun Singh; Anil D'Cruz
Journal:  Indian J Surg Oncol       Date:  2018-09-03

2.  The frequency of high-risk human papillomavirus types, HPV16 lineages, and their relationship with p16INK4a and NF-κB expression in head and neck squamous cell carcinomas in Southwestern Iran.

Authors:  Fatemeh Pakdel; Ali Farhadi; Tahereh Pakdel; Azadeh Andishe-Tadbir; Parnian Alavi; Abbas Behzad-Behbahani; Mohammad J Ashraf
Journal:  Braz J Microbiol       Date:  2020-11-09       Impact factor: 2.476

3.  Exome Sequencing with Validations and Expression of p16/CDKN2A Shows no Association with HPV in Oral Cancers.

Authors:  Vidyarani Shyamsundar; Soundara Viveka Thangaraj; Arvind Krishnamurthy; Sanjana Vimal; Pallavi Kesavan; Aravinda Babu; Masthan Kmk; Vijayalakshmi Ramshankar
Journal:  Asian Pac J Cancer Prev       Date:  2022-01-01

4.  Prevalence of human papillomavirus types in head and neck cancer sub-sites in the Indian population.

Authors:  Devyani Gholap; Sharayu Mhatre; Pankaj Chaturvedi; Sudhir Nair; Tarik Gheit; Massimo Tommasino; Rajesh Dikshit
Journal:  Ecancermedicalscience       Date:  2022-02-18

5.  Comparative assessment of HPV, alcohol and tobacco etiological fractions in Algerian patients with laryngeal squamous cell carcinoma.

Authors:  Nora Kariche; Montserrat Torres Hortal; Samir Benyahia; Laia Alemany; Nabila Moulaï; Omar Clavero; Marleny Muñoz; Wahiba Ouahioune; Djamel Djennaoui; Chafia Touil-Boukoffa; Silvia de Sanjosé; Mehdi Bourouba
Journal:  Infect Agent Cancer       Date:  2018-03-13       Impact factor: 2.965

6.  Development and validation of a protocol for optimizing the use of paraffin blocks in molecular epidemiological studies: The example from the HPV-AHEAD study.

Authors:  Marisa Mena; Belen Lloveras; Sara Tous; Johannes Bogers; Fausto Maffini; Nitin Gangane; Rekha Vijay Kumar; Thara Somanathan; Eric Lucas; Devasena Anantharaman; Tarik Gheit; Xavier Castellsagué; Michael Pawlita; Silvia de Sanjosé; Laia Alemany; Massimo Tommasino
Journal:  PLoS One       Date:  2017-10-16       Impact factor: 3.240

7.  Role of mucosal high-risk human papillomavirus types in head and neck cancers in Romania.

Authors:  Ramona Gabriela Ursu; Mihai Danciu; Irene Alexandra Spiridon; Ruediger Ridder; Susanne Rehm; Fausto Maffini; Sandrine McKay-Chopin; Christine Carreira; Eric Lucas; Victor-Vlad Costan; Eugenia Popescu; Bogdan Cobzeanu; Nicolae Ghetu; Luminita Smaranda Iancu; Massimo Tommasino; Michael Pawlita; Dana Holzinger; Tarik Gheit
Journal:  PLoS One       Date:  2018-06-25       Impact factor: 3.240

Review 8.  Current Updates on Cancer-Causing Types of Human Papillomaviruses (HPVs) in East, Southeast, and South Asia.

Authors:  Chichao Xia; Sile Li; Teng Long; Zigui Chen; Paul K S Chan; Siaw Shi Boon
Journal:  Cancers (Basel)       Date:  2021-05-30       Impact factor: 6.639

9.  Prevalence of Human Papilloma Virus Sub Genotypes following Head and Neck Squamous Cell Carcinomas in Asian Continent, A Systematic Review Article.

Authors:  Naeem Bukhari; Joe P Joseph; Sayed Sajid Hussain; Muhammad Adeeb Khan; Marcel Jose Yibirin Wakim; Esam Bashir Yahya; Amina Arif; Afshan Saleem; Nadeem Sharif
Journal:  Asian Pac J Cancer Prev       Date:  2019-11-01

10.  Role of human papillomavirus infection in the etiology of vulvar cancer in Italian women.

Authors:  Mario Preti; John Charles Rotondo; Dana Holzinger; Leonardo Micheletti; Niccolò Gallio; Sandrine McKay-Chopin; Christine Carreira; Sebastiana Silvana Privitera; Reiko Watanabe; Ruediger Ridder; Michael Pawlita; Chiara Benedetto; Massimo Tommasino; Tarik Gheit
Journal:  Infect Agent Cancer       Date:  2020-04-01       Impact factor: 2.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.